SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-24-025667
Filing Date
2024-02-20
Accepted
2024-02-20 18:57:58
Documents
1
Group Members
DR. JAMES I. HEALYSOFINNOVA MANAGEMENT IX, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm246499d2_sc13da.htm SC 13D/A 94092
  Complete submission text file 0001104659-24-025667.txt   95753
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Subject) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91201 | Film No.: 24655708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners IX, L.P. (Filed by) CIK: 0001612133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A